Company intelligence / Profile preview

Jorgensen Biotech Consulting

Ownership: Private
Development stage: Other

Overview

Jorgensen Biotech Consulting is led by Thomas Kjærsgaard Jørgensen, an executive with extensive experience in biotechnology and pharmaceutical development. The firm provides strategic and operational consulting services to companies in the life sciences sector. The CEO’s background includes leadership roles at major biopharma companies such as Novo Nordisk, AstraZeneca R&D, Maxygen ApS, Symphogen A/S, Chr. Hansen A/S, Savara Inc., and ResoTher Pharma—covering areas like CMC (Chemistry Manufacturing & Controls), bioanalysis, clinical operations, protein purification/characterization, microbiome research management, project direction for oncology/biologics programs. The company itself does not appear to run its own drug development programs or maintain an internal therapeutic pipeline.

Industry: Consulting

Beyond the preview

Go deeper on Jorgensen Biotech Consulting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jorgensen Biotech Consulting.

Explore the full profile